Nucletron, an Elekta company, reaches major milestone with its brachytherapy treatment planning software
"We chose Flexitron because it is a highly advanced brachytherapy platform that met all our requirements"
Michael F. Sarosdy, MD, is convinced that brachytherapy is a far better choice than surgery for most men with prostate cancer
Nucletron continues its role of a center of excellence in the development of Brachytherapy Solutions as “Nucletron, an Elekta company”.
The scalable and upgradable platform with 6, 18 or 30 channels suits the needs of many brachytherapy patients and healthcare professionals
A brachytherapy solution that enables very precise dose delivery for gynecologic cancers
An update for Nucletron customers about Elekta's acquisition of Nucletron
Through the combination Elekta will offer a complete range of radiotherapy planning and delivery technologies
Elekta has agreed to acquire Nucletron for EUR 365 million in cash
Aboutbrachytherapy.com certified as a provider of trustworthy health information
Product innovation underscores commitment to radiotherapy and global market leadership in brachytherapy
The new outlook is based on a strong Q1 2011
Brachytherapy Center to focus on effective patient treatment and research
Leading experts meet to discuss advances in prostate cancer treatment
Driven by a strong growth in North America and Asia Pacific, sales grew 14% to EUR 128.2 million
VMAT reduces the treatment time and significantly reduces the risk of serious side effects
"VelocityAI has been a great tool for achieving the precision required in radiosurgery"
Nucletron India Training Academy provides professional knowledge of precision cancer treatment
Dutch hospital successfully treated 30 cancer patients with the latest brachytherapy equipment
New brachytherapy solutions for prostate cancer focus on five positive aspects for both patients and clinics
VelocityAI is instrumental in a research project at the University of Virginia designed to treat these patients much faster
A new treatment option for the boost dose as part of the Whole Breast Irradiation treatment after lumpectomy
First cancer patients treated with Nucletron’s prostate HDR brachytherapy solution in The Specialized Hospital for Active Treatment in Oncology in Sofia
Ahmed Taha appointed as General Manager of new office in Dubai
Companies unite in development of unique platform for Nucletron’s treatment planning systems for prostate brachytherapy
Global marketing collaboration offers innovative imaging functionality that complements Nucletron Oncentra
Exciting new solutions for precision cancer treatment on display during ESTRO29 in Barcelona, Spain
Peter Kingma brings wealth of medical device experience to Nucletron
New Release Previews Exponential Gains in Speed
More than 100 participants discuss the benefits of Oncentra Brachy in Valencia, Spain
University Hospital Regensburg is one of several European hospitals now treating patients with Oncentra VMAT
More than 250 hospitals and clinics have migrated from PLATO to Oncentra
Nucletron is speeding up the performance of dose calculations for external beam treatment
Nucletron strengthened its market position in 2009 due to a strong performance under challenging market conditions
Agreement will aid the institute in the development of treatment techniques for head and neck, breast, lung and prostate patients using rotational therapy
Nucletron aims to bring advanced treatments such as brachytherapy within easier reach with the new establishment in Russia
Confirmed better biological control with loose seeds brachytherapy.
University Hospital Regensburg (UHR) First to Treat Patients with Nucletron Oncentra VMAT Software Solution
Extra functionalities for even more precise treatment planning on display during first European Oncentra Brachy Best Practice Workshop
Innovative New Breast Irradiation Treatment Will Serve the Jackson Park Community of Southside Chicago
Meeting follows launch of Brachytherapy campaign and the launch of aboutbrachytherapy.com
El Camino Hospital’s New Radiation Oncology Center to Serve as West Coast Center of Excellence for HDR Brachytherapy
The new simulator enables patients to benefit from faster and more precise cancer radiation treatments
High Success Rate Leads to Expansion of State-of-the-Art Irradiation Program
Survey Results Demonstrate Need to Help Patients Make Informed Cancer Treatment Decisions
Three out of four cancer patients unaware of brachytherapy
The Istituto Europeo di Oncologia is the first hospital in Europe to use AccuBoost
Walter Tarca Brings Experience and a Successful Record of Healthcare Innovation to His New Role
Istituto Europeo di Oncologia in Milan, Italy the first European hospital to treat breast cancer patients with AccuBoost
New Release Includes Functionality for VMAT Planning and Model Based Segmentation for Clinical Use
Robert Fenwick has joined the company as vice president of external beam treatment planning
Major Swedish University Hospital Chooses Independent and Flexible Oncentra VMAT Planning Solution from Nucletron
Vendor Independent and Flexible Solution offering lightning fast calculations
It takes just a couple of hours and patients are usually home for tea. This is brachytherapy, or high precision radiotherapy.
Customer Finance Solution Provides New Opportunities to Establish or Expand HDR Brachytherapy Practice
First HDR brachytherapy treatment for prostate cancer recently performed in Helsinki
Developments in open treatment planning - Oncentra®, an independent treatment planning system that gives you the freedom of choice.
Nucletron Announces the First U.S. Patient Treatment with the Flexitron Brachytherapy Treatment Delivery Solution at the Cancer Specialists of Oklahoma Cancer Center
Nucletron exclusive distributor of Isodose Control products
Despite challenging global economic conditions, Nucletron surpassed projections for the first half year
Published article in the Public Service Review, Issue 20, Summer 2009
Nucletron invites you to Maastricht and see exciting innovations in the field of radiotherapy
Clinicians gain access to the latest innovations now and in the future
The new members of Nucletron’s executive management team include industry professionals with extensive medical, research and marketing expertise.
Fully CT/MR Compatible Utrecht Interstitial Fletcher and Interstitial Ring Applicators Raise the Standard of Care for Gynecologic Cancers
Special project started for customers to migrate from PLATO to Oncentra
Upgrading to Oncentra Simulation is an extremely cost effective way to extend the useful life of your Simulix simulator
Nucletron and Isodose Control plan to join forces
Elekta and Nucletron have reached an agreement to market and license Elekta’s software system MOSAIQ®
New release of Oncentra Brachy presented at GEC ESTRO 2009
Easily find the applicators and accessories you need
Strong Product Offerings and Leadership in Brachytherapy Contribute to All-Time High
Oncentra Simulation 2.3 provides DICOM connectivity with increased efficiency and accuracy with electronic simulation
The Chulalongkorn University Hospital in Bangkok/Thailand Treats Their First Gynecologic Patient
Pay-Per-Patient Pricing Available to Reduce Start-Up Barriers for Cancer Centers
First patient treated with groundbreaking treatment planning solution for gynecologic cancer
Nucletron and Raysearch collaborate on two new solutions for external beam treatment planning
Strong relationship between UMC Utrecht and Nucletron leads to purchase
510 (k) Clearance for Oncentra RT Viewer
Oncentra® Brachy Receives Canadian Regulatory Clearance
Nucletron has been able to obtain sufficient quantities of irradiated iridium from the BR2 reactor in Mol, Belgium
Partnership enables acceleration of transition to 3D volumetric APBI treatment options
First commercially available software to review and share DICOM RT treatment plans for radiotherapy
Nucletron and AKH Vienna have extended their longstanding cooperation through a multi-tiered partnership to advance image-guided adaptive brachytherapy for gynecology
Jos Lamers Brings Years of International Senior Management
One-week intensive fellowship program provides residents with clinical and technical training in brachytherapy